Mazanti-Andersen advised Hemab on the deal. The Denmark and US-based biotech company Hemab raised USD 135 million in oversubscribed series B financing. Access Biotechnology led the round...
You must be a Standard 1 Year member to access this content.
Mazanti-Andersen advised Upfin on the deal. Upfin is a new venture capital fund dedicated to supporting the Nordic fintech community. Its first fund has raised DKK...
You must be a Standard 1 Year member to access this content.
Kromann Reumert and Sidley Austin LLP advised KKR on its purchase. Mazanti-Andersen advises the sellers. Nordic Bioscience A/S, a Danish company and world leader in biomarker...
You must be a Standard 1 Year member to access this content.
